Adopt the Ensuring Transparency in Prior Authorization Act and provide for insurance and medicaid coverage of biomarker testing

This bill, known as the Ensuring Transparency in Prior Authorization Act, aims to make the prior authorization process for healthcare services more clear and efficient. It sets new rules for how insurance companies handle prior authorization requests, including requirements for timely decisions and accessible information. The bill also mandates that insurance plans and Medicaid cover biomarker testing for certain conditions starting in 2028, provided the tests have clinical utility.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text